Biotech · Private company
Allergy Therapeutics
Track this companyFree. Adds Allergy Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- PQ GrassPhase 3 · Rhinitis, Allergic, SeasonalClinicalTrials.gov · fetched Nov 12, 2026
- PQ GrassPhase 3 · Seasonal Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- Grass MATA (0.5ml) 5100SUPhase 2 · Seasonal Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- Grass MATA MPL (0.5ml) 5100SUPhase 2 · Seasonal Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- Grass MATA MPL (1.0ml) 10200SUPhase 2 · Seasonal Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- Grass MATA MPL (1.0ml) 18200SUPhase 2 · Seasonal Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- RagweedMATAMPLPhase 2 · Type I HypersensitivityClinicalTrials.gov · fetched Nov 12, 2026
- Grass MATA MPLPhase 1 · Seasonal Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- VLP PeanutPhase 1 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic SubjectsPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 17, 2022ClinicalTrials.gov NCT05476497 · fetched Nov 12, 2026
- Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass PollenPHASE3 · COMPLETED · started Oct 11, 2022ClinicalTrials.gov NCT05540717 · fetched Nov 12, 2026
- An Exploratory Study of PQ Grass 27600 SUPHASE2_PHASE3 · COMPLETED · started Oct 19, 2020ClinicalTrials.gov NCT04687059 · fetched Nov 12, 2026
- A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPLPHASE1 · COMPLETED · started Jan 16, 2017ClinicalTrials.gov NCT03931993 · fetched Nov 12, 2026
- Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™PHASE2 · COMPLETED · started Nov 7, 2015ClinicalTrials.gov NCT02582073 · fetched Nov 12, 2026
- Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick TestPHASE2 · COMPLETED · started Nov 1, 2005ClinicalTrials.gov NCT00258635 · fetched Nov 12, 2026